Benefits
Provides a plant-based omega-3 source
Cold-pressed sacha inchi oil is one of the most concentrated dietary sources of alpha-linolenic acid, making it a useful plant-based omega-3 option for people who avoid fish or fish oil, and providing a precursor that the body converts to longer-chain omega-3s only inefficiently. Because that conversion is limited, especially for DHA, sacha inchi oil is not interchangeable with fish or algal oil, which supply EPA and DHA directly.
Helps support a healthy lipid profile
In one small trial, 24 adults with diagnosed hyperlipoproteinemia who took 5 mL or 10 mL of sacha inchi oil daily for four months had lower mean total cholesterol and non-esterified fatty acids and higher HDL cholesterol, and the higher dose was also associated with a rise in insulin. That is a description of what happened in a single small trial in a diagnosed patient population, not evidence that sacha inchi oil lowers cholesterol in generally healthy people. Sacha inchi oil is best used as one unsaturated-fat choice within an overall heart-healthy dietary pattern.
Supports normal essential fatty acid intake
Sacha inchi seeds and oil provide both alpha-linolenic acid and linoleic acid in proportions favoring omega-3, helping support adequate essential fatty acid intake in diets that may otherwise be skewed toward omega-6 sources.
Contributes plant protein and tocopherols
Whole roasted sacha inchi seeds supply plant protein along with tocopherols and minor antioxidant constituents, contributing to nutrient diversity and overall antioxidant support when used as a snack or recipe ingredient.
Mechanism of action
ALA precursor for EPA and DHA
Alpha-linolenic acid from sacha inchi oil undergoes partial elongation and desaturation in the liver to produce EPA and small amounts of DHA, providing precursor supply for the omega-3 long-chain pathway when fish-derived sources are absent.
Modulation of lipid metabolism and lipoproteins
Diets enriched in ALA have been shown to reduce VLDL secretion and improve lipoprotein profiles, providing a mechanism for the modest reductions in total cholesterol and increases in HDL reported in the single small sacha inchi oil trial cited here.
Anti-inflammatory eicosanoid signaling
EPA and oxylipins derived from ALA competition with arachidonic acid pathways generate less pro-inflammatory eicosanoids and contribute to resolving lipid mediators, providing a mechanistic basis for cardiovascular and inflammation-related effects of plant-based omega-3 intake.
Clinical trials
Open-label pilot study of sacha inchi oil suspension orally (5 mL or 10 mL doses) for 4 months in adults with elevated cholesterol (Garmendia, Pando, Ronceros; Rev Peru Med Exp Salud Publica).
24 adults aged 35–75 with hyperlipoproteinemia.
Sacha inchi oil consumption reduced mean total cholesterol and non-esterified fatty acids and increased HDL cholesterol in both dose subgroups, with the higher 10 mL dose also associated with rises in insulin. Because the study enrolled just 24 people and was conducted only in adults with a diagnosed lipid disorder, the results are preliminary and cannot establish that sacha inchi oil changes cholesterol in the general population.
Crossover study of single oral doses of sacha inchi oil versus sunflower oil with plasma fatty acid measurements over 24 hours (Gonzales et al., Toxicology Mechanisms and Methods).
18 healthy human adult volunteers.
Sacha inchi oil elevated plasma alpha-linolenic acid and DHA, with peak ALA at 2 hours and higher concentrations in female participants, demonstrating that ALA from sacha inchi oil is absorbed and modestly elevates long-chain omega-3 in plasma compared with sunflower oil. This was a single-dose pharmacokinetic and tolerability study rather than an efficacy trial: it tracked blood fatty acid levels over 24 hours and did not measure any health outcome. The authors also recorded gastrointestinal intolerance, including nausea, in some participants after the oil.